Pioglitazole and metformin hydrochloride

CHEBI:CHEBI_753854

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
861822
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
route
ORAL
dosage_form
TABLET
marketing_category
ANDA
active_ingredient_strength
500 mg/1
active_ingredient_name
PIOGLITAZONE HYDROCHLORIDE
unii
JQT35NPK6C
pharm_class
Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]
labeler_name
Macleods Pharmaceuticals Limited
manufacturer_name
Macleods Pharmaceuticals Limited
marketing_start_date
20151106
package_marketing_start_date
20151106
generic_name
Pioglitazole and metformin hydrochloride
brand_name
Pioglitazole and metformin hydrochloride
brand_name_base
Pioglitazole and metformin hydrochloride
product_ndc
33342-176
application_number
ANDA204802
spl_id
b8d1b218-f2b7-4f70-859d-481fd9b9add0
package_ndc
33342-176-57
package_description
180 TABLET in 1 BOTTLE (33342-176-57)
spl_set_id
5ff2cd9e-a579-48f5-845f-c37a68372a34
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class